APPETON Essentials Multi-Vit plus Effervescent Tablet
APPETON Essentials Multi-Vit plus Effervescent Tablet : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL17096007NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- KOTRA PHARMA (M) SDN. BHD.
- Manufacturer
- LONNIX (M) SDN. BHD.
- Registration period starting
- 2022-09-07
- Published validity end
- 2027-09-07
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| CALCIUM PANTOTHENATE | CALCIUM PANTOTHENATE[5.43 mg,4.5 gm] | Acide pantothénique (vitamine B5) |
| DL-ALPHA TOCOPHERYL ACETATE | DL-ALPHA TOCOPHERYL ACETATE[20 mg,4.5 gm] | Vitamine E |
| CHROMIUM PICOLINATE | CHROMIUM PICOLINATE[1.61 mg,4.5 gm] | Chrome |
| THIAMINE HYDROCHLORIDE | THIAMINE HYDROCHLORIDE[1.4 mg,4.5 gm] | Vitamine B1 (thiamine) |
| RIBOFLAVIN SODIUM PHOSPHATE | RIBOFLAVIN SODIUM PHOSPHATE[1.5 mg,4.5 gm] | Vitamine B2 (riboflavine) |
| PYRIDOXINE HYDROCHLORIDE | PYRIDOXINE HYDROCHLORIDE[1.58 mg,4.5 gm] | Vitamine B6 |
| CYANOCOBALAMIN | CYANOCOBALAMIN[2.4 mg,4.5 g] | Vitamine B12 |
| CHOLECALCIFEROL | CHOLECALCIFEROL[0.0065 mg,4.5 g] | Vitamine D |
| ASCORBIC ACID (VITAMIN C) | ASCORBIC ACID (VITAMIN C)[75 mg,4.5 gm] | Vitamine C |
| NIACINAMIDE | NIACINAMIDE[14 mg,4.5 g] | Nicotinamide (vitamine B3) |
| BIOTIN | BIOTIN[0.029 mg,4.5 g] | Biotine (vitamine B8) |
| RETINYL ACETATE | RETINYL ACETATE[5.72 mg,4.5 g] | Vitamine A |
| FOLIC ACID | FOLIC ACID[0.4 mg,4.5 g] | Folates (vitamine B9) |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- CALCIUM PANTOTHENATE[5.43 mg,4.5 gm],DL-ALPHA TOCOPHERYL ACETATE[20 mg,4.5 gm],CHROMIUM PICOLINATE[1.61 mg,4.5 gm],THIAMINE HYDROCHLORIDE[1.4 mg,4.5 gm],RIBOFLAVIN SODIUM PHOSPHATE[1.5 mg,4.5 gm],PYRIDOXINE HYDROCHLORIDE[1.58 mg,4.5 gm],CYANOCOBALAMIN[2.4 mg,4.5 g],CHOLECALCIFEROL[0.0065 mg,4.5 g],ASCORBIC ACID (VITAMIN C)[75 mg,4.5 gm],NIACINAMIDE[14 mg,4.5 g],BIOTIN[0.029 mg,4.5 g],RETINYL ACETATE[5.72 mg,4.5 g],FOLIC ACID[0.4 mg,4.5 g]
- Valid until
- 2027-09-07
- Registration date
- 2022-09-07
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- KOTRA PHARMA (M) SDN. BHD.
- Producer
- LONNIX (M) SDN. BHD.
- Published name
- APPETON Essentials Multi-Vit plus Effervescent Tablet
- Published reference
- 201703060054N
- Registration number
- MAL17096007NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL17096007NC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- CHOLECALCIFEROL
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.